Integra LifeSciences Holdings Corporation (IART) revenue

Revenue · fiscal 2025
$1.64B

Integra LifeSciences Holdings Corporation (IART) reported revenue of $1.64B in fiscal 2025 (the year ended December 31, 2025). That is 1.5% higher than the $1.61B of fiscal 2024. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.64B
Change on fiscal 2024
+1.5%
Growth, 5 years
+3.6% a year
Growth, 10 years
+6.4% a year
Highest on record
$1.64Bfiscal 2025
Lowest on record
$654.60Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Integra LifeSciences Holdings Corporation revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 3.6% a year; over ten years the rate was 6.4% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.64B in fiscal 2025 and the lowest $654.60M in fiscal 2008.

History · 18 fiscal years

Revenue by fiscal year

Integra LifeSciences Holdings Corporation revenue, year by year

Integra LifeSciences Holdings Corporation (IART) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.64B 1.5% up
2024$1.61B 4.5% up
2023$1.54B 1.0% down
2022$1.56B 1.0% up
2021$1.54B 12.4% up
2020$1.37B 9.6% down
2019$1.52B 3.1% up
2018$1.47B 23.9% up
2017$1.19B 19.8% up
2016$992.08M 12.4% up
2015$882.73M 10.8% up
2014$796.72M 14.3% up
2013$696.83M 16.1% down
2012$830.87M 6.5% up
2011$780.08M 6.6% up
2010$732.07M 7.3% up
2009$682.49M 4.3% up
2008$654.60M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on IART

Integra LifeSciences Holdings Corporation, figure by figure

Integra LifeSciences Holdings Corporation (IART) overview: price, valuation and scorecard

Integra LifeSciences Holdings Corporation revenue: questions and answers

What is Integra LifeSciences Holdings Corporation's revenue?

Integra LifeSciences Holdings Corporation (IART) reported revenue of $1.64B in fiscal 2025 (the year ended December 31, 2025). That is 1.5% higher than the $1.61B of fiscal 2024.

What is the growth rate of Integra LifeSciences Holdings Corporation's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 3.6% a year; over ten years the rate was 6.4% a year.

What are the highest and lowest revenue figures on record for Integra LifeSciences Holdings Corporation?

Across the 18 fiscal years on record (2008–2025), the highest was $1.64B in fiscal 2025 and the lowest $654.60M in fiscal 2008.

How is Integra LifeSciences Holdings Corporation's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Integra LifeSciences Holdings Corporation it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Integra LifeSciences Holdings Corporation (IART) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/IART/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.